These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23722528)

  • 1. Cardiovascular comorbidity in COPD: systematic literature review.
    Müllerova H; Agusti A; Erqou S; Mapel DW
    Chest; 2013 Oct; 144(4):1163-1178. PubMed ID: 23722528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk.
    Brook RD; Anderson JA; Calverley PM; Celli BR; Crim C; Denvir MA; Magder S; Martinez FJ; Rajagopalan S; Vestbo J; Yates J; Newby DE;
    Heart; 2017 Oct; 103(19):1536-1542. PubMed ID: 28416587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.
    Sidney S; Sorel M; Quesenberry CP; DeLuise C; Lanes S; Eisner MD
    Chest; 2005 Oct; 128(4):2068-75. PubMed ID: 16236856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics].
    Ambatiello LG; Chazova IE
    Ter Arkh; 2020 Apr; 92(3):78-83. PubMed ID: 32598797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.
    Finkelstein J; Cha E; Scharf SM
    Int J Chron Obstruct Pulmon Dis; 2009; 4():337-49. PubMed ID: 19802349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease and cardiovascular disease.
    Bhatt SP; Dransfield MT
    Transl Res; 2013 Oct; 162(4):237-51. PubMed ID: 23727296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective study on the prevalence of cardiovascular comorbidities in 4960 inpatients with chronic obstructive pulmonary disease in Beijing].
    Wei ZM; Cai JF; Cui H; Liu AM; Li Y; Gao F; Fan L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Mar; 32(3):297-301. PubMed ID: 21457669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease.
    Khedoe PP; Rensen PC; Berbée JF; Hiemstra PS
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1011-27. PubMed ID: 26993520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Chen W; Thomas J; Sadatsafavi M; FitzGerald JM
    Lancet Respir Med; 2015 Aug; 3(8):631-9. PubMed ID: 26208998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic obstructive pulmonary disease and cardiovascular comorbidity].
    Aisanov ZR; Chuchalin AG; Kalmanova EN
    Kardiologiia; 2019 Sep; 59(8S):24-36. PubMed ID: 31526359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Morbidity in Individuals with Impaired FEV1.
    Mathew J; Nickel NP
    Curr Cardiol Rep; 2022 Mar; 24(3):163-182. PubMed ID: 35038132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic obstructive pulmonary disease and cardiovascular diseases--'cardiopulmonary continuum'].
    Batura-Gabryel H; Grabicki M
    Pneumonol Alergol Pol; 2014; 82(6):590-6. PubMed ID: 25339571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
    Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease.
    Ooi H; Chen LH; Ni YL; Shen HT; Lee YH; Chu YC; Fang KC; Chen IH; Hsu SL; Chen HC; Huang CH; Fan KS; Lai CL; Hang LW
    Clin Respir J; 2018 Mar; 12(3):1038-1045. PubMed ID: 28268258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort.
    Johnston AK; Mannino DM; Hagan GW; Davis KJ; Kiri VA
    Thorax; 2008 Jul; 63(7):599-605. PubMed ID: 18245145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease.
    Onishi K
    J Cardiol; 2017 Aug; 70(2):128-134. PubMed ID: 28325523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study).
    Figueira Gonçalves JM; Dorta Sánchez R; Rodri Guez Pérez MDC; Viña Manrique P; Díaz Pérez D; Guzmán Saenz C; Palmero Tejera JM; Pérez Rodríguez A; Pérez Negrín L
    Clin Investig Arterioscler; 2017; 29(4):149-156. PubMed ID: 28390852
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.